Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Abnormal, addressing, advisory, allograft, ANA, apportionment, Aptuit, arm, ASP, beneficiary, bound, broader, Broadly, bulk, clarification, CMS, complication, constitutionality, construed, contributory, deceased, deprioritization, deprioritize, detaining, developmental, deviating, DGF, disagreement, disapproval, distort, EFTA, Elan, endorse, exploring, fit, floating, forgivable, Frank, Georgia, Glasgow, Glaxo, graft, harmonization, hinder, HTA, Iceland, ICH, ineligibility, infant, injury, inpatient, Inspector, introduced, IRB, Irish, John, Justice, Kingdom, landlord, Liechtenstein, manifestation, Marken, MGPN, MINE, morbidity, Moriarty, MPGN, natriuretic, network, NICE, Nonrefundable, Norway, orderly, outsourcing, penalized, PIP, plc, premature, procurement, programme, prosecutor, pyrophosphate, relapsing, reliance, relocate, rentable, repaid, repurchase, repurchased, safer, saleable, seizing, sequester, simultaneously, SmPC, societal, speaking, Specialised, spread, stay, step, Strathclyde, strictly, stringent, Supreme, Sweden, threat, toxicology, transforming, Transparency, transparent, untitled, upheld, variation, voluntary, waiver, Wright, younger
Removed:
AAT, Amherst, asserting, Belgium, Boehringer, circulatory, classify, CLL, closure, collateralized, College, Computation, computing, consumed, Corange, CPA, Cravath, created, DDD, Diego, discomfort, dry, Dubin, earned, enrolment, expiring, founded, hold, HUS, imputed, joined, Latin, leukemia, lymphocytic, Maine, managed, managerial, Mannheim, merged, mild, million, Moore, myeloma, negligible, neoplasm, OCI, payor, percent, plasma, PMSI, prosecuted, ran, rarely, rated, recover, redeem, regulator, release, samalizumab, San, Sandoz, Searle, spent, SRF, Swaine, tenure, treating, uncollectable, Upjohn
Filing tables
Filing exhibits
- 10-K Annual report
- 21.1 Subsidiaries of Alexion Pharmaceuticals, Inc.
- 23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO Pursuant to Section 906
- 32.2 Certification of CFO Pursuant to Section 906
Related press release
ALXN similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S‑3 (No. 333-181595, 333-128085, 333-127471, 333-123828, 333-91265, 333-29617, 333-41397, 333-47645, 333-89343, 333-36738, 333-52886 and 333-59702) and Form S-8 (No. 333-146319, 333-139600, 333-123212, 333-119749, 333-24863, 333-52856, 333-69478, 333-71879, 333-71985, 333-106854 and 333-153612) of Alexion Pharmaceuticals, Inc. of our report dated February 19, 2013 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Hartford, Connecticut
February 19, 2013